Plasma-Induced Amine-Modified PEEK Promotes Osteointegration via Multiple Osteogenic Pathways and Macrophage
Takuya Furuichi1, Hiromasa Hirai2, Takayuki Kitahara1
1Department of Orthopedic Surgery, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan.
Plasma treatment of Polyetheretherketone (PEEK) enhances bone bonding for orthopedic implants. This surface modification improves osteogenic potential, promoting better bone formation and implant stability compared to untreated PEEK.
Area of Science:
- Biomaterials Science
- Orthopedic Engineering
- Surface Chemistry
Background:
- Polyetheretherketone (PEEK) is widely used in orthopedic devices due to its favorable mechanical and chemical properties.
- However, PEEK's biological inertness limits initial fixation and bone integration, potentially compromising implant success.
- Existing surface modification methods for PEEK have drawbacks, including inconsistent roughness and wear debris generation.
Purpose of the Study:
- To investigate the osteogenic effects of PEEK modified by plasma-enhanced chemical vapor deposition (PECD) with a carbonaceous thin film containing amine groups.
- To elucidate the underlying molecular mechanisms responsible for enhanced bone formation.
- To evaluate the in vivo performance of plasma-treated PEEK in a rat femur model.
Main Methods:
- PEEK surface modification using plasma-enhanced chemical vapor deposition (PECD) with CH4/N2 gas.
- In vitro assessment of hydrophilicity, cell adhesion, and osteoblastic differentiation.
- RNA sequencing analysis to identify signaling pathways involved in osteogenesis.
- In vivo implantation into rat femurs to evaluate bone-bone bonding and tissue response.
Main Results:
- Plasma-treated PEEK exhibited enhanced hydrophilicity and cell adhesion without altering surface roughness.
- In vitro studies showed promoted osteoblastic differentiation on plasma-treated PEEK.
- RNA sequencing revealed activation of FAK and BMP4/Smad signaling pathways.
- In vivo, plasma-treated PEEK demonstrated bone formation without fibrous tissue intervention, unlike untreated PEEK, with superior bone quality at 6 weeks.
Conclusions:
- Plasma treatment using PECD effectively enhances the osteogenic potential of PEEK by improving surface properties and activating key signaling pathways.
- This modification overcomes the biological inertness of PEEK, leading to improved bone bonding and implant integration.
- Plasma-treated PEEK shows significant promise as a next-generation biomaterial for orthopedic applications.
More Related Videos
10:32Author Spotlight: Simple Establishment of a Vascularized Osteogenic Bone Marrow Niche Using Pre-Cast Poly(Ethylene Glycol) (PEG) Hydrogels in an Imaging Microplate
Published on: May 19, 2023
12:27Polyelectrolyte Complex for Heparin Binding Domain Osteogenic Growth Factor Delivery
Published on: August 22, 2016
